May 16, 2023
Pfizer has launched a Phase 3 study of its RSV vaccine candidate and researchers at the George Washington University are studying the vaccine’s safety and ability to trigger an immune response in two groups of people at risk for severe illness caused by respiratory syncytial virus or RSV.
Study: Survey Methodology Should Be Calibrated to Account for Negative Attitudes About Immigrants and Asylum-Seekers
May 12, 2023
As of 2021 it is estimated that world-wide the number of refugees and asylum-seekers is over 31 million. While academics and researchers have been attempting to capture global and domestic attitudes towards these vulnerable groups, many of these studies will report biased findings and influence…
May 3, 2023
George Washington University (GW) is excited to share that it launched its chapter of the National Academy of Inventors (NAI) on the 26th of April, 2023. The NAI is an esteemed organization that honors academic inventors and acknowledges the impact of their groundbreaking discoveries on society,…
Study: New Drug Combination Holds Unusually Positive Results for HPV-Negative Patients with Advanced Head and Neck Cancer
March 28, 2023
A new combination drug treatment showed promising results in patients with pan-refractory, recurrent/metastatic head and neck cancer, according to a study published today in the Journal of Clinical Oncology.
GW SMHS to Provide Academic Support for the Ibn Sina University for Medical Sciences in Amman, Jordan
March 28, 2023
The Office of International Medicine Programs (IMP) at the George Washington University (GW) School of Medicine and Health Sciences (SMHS) has just initiated a six-year contract with Ibn Sina University for Medical Sciences (ISUMS), the first private medical school in Amman, Jordan.
Mohamad Koubeissi, MD, FAAN, FANA, FAES, to Serve as Interim Chair of the GW Department of Neurology and Rehabilitation Medicine
March 23, 2023
Mohamad Koubeissi, MD, FAAN, FANA, FAES, professor of neurology, has been selected to serve as interim chair of the Department of Neurology and Rehabilitation Medicine. Out-going Department Chair Henry Kaminski, MD, will continue to serve the academic medical enterprise in several missions.
March 23, 2023
A pair of Phase III trials led by Jonathan I. Silverberg, MD, PhD, suggest a 16-week treatment with a drug called lebrikizumab was effective in adults and adolescents with moderate to severe dermatitis. The study results were published in the March 15 edition of the New England Journal of Medicine.
March 16, 2023
George Washington University School of Medicine and Health Sciences Department of Dermatology faculty, residents, and students have a large-scale, high-impact presence during the 2023 American Academy of Dermatology (AAD) Meeting, March 17–21 in New Orleans, Louisiana.
March 7, 2023
Elmer Huerta, MD, MPH, director of the Cancer Preventorium at the George Washington University Cancer Center, has been invited to participate in the White House Cancer Moonshot Colorectal Cancer Forum.
GW School of Medicine and Health Sciences and the GW MFA Recruiting Participants for Final Stage of the NIAID’s COVAIL Trial
October 19, 2022
The GW School of Medicine and Health Sciences is recruiting participants for the final stage of a clinical trial to evaluate two Omicron-specific vaccines. The study, known as the COVID-19 Variant Immunologic Landscape (COVAIL) trial, is sponsored by the National Institute of Allergy and Infectious…